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[introduction] There have been increasing number of reports of SZT2-related 
neurological diseases, the main symptoms of which are epilepsy, developmental delay, 
macrocephaly and a dysmorphic corpus callosum. SZT2 functions as a regulator of 
mechanistic target of rapamycin complex 1 (mTORC1) signaling in cultured human cell 
lines and mouse tissues. However, it remains to be determined whether mutations in 
SZT2 in human patients alter mTORC1 signaling. In this study, we aimed to investigate 
the functional consequence of biallelic SZT2 variants in Epstein-Barr virus-induced 
lymphoblastoid cell lines (LCLs) established from two patients with a typical 
SZT2-related neurodevelopmental disease.  
[Materials and methods] We evaluated two patients with SZT2 variants who have 
already been described, and three healthy control subjects. Epstein-Barr virus-induced 
LCLs were established from peripheral blood using a standard method. 
[Results] Increased phosphorylation of S6 kinase and S6 was identified in 
patient-derived cell lines under amino acid-starved condition, suggestive of constitutive 
hyperactivation of mTORC1 signaling. This result was validated by constitutive 
lysosomal localization of mTOR in patients’ LCLs. Furthermore, patients’ LCLs display 
an excessive response to slight amino acid stimulation.  
[Discussion] Our data suggest the loss-of-function nature of SZT2 mutations in the 
patients, and consequent hyperactivation of mTORC1 signaling in response to both 
amino acid starvation and stimulation in their LCLs. By these functional analyses, the 
pathogenicity of newly identified SZT2 variants can be determined, allowing for more 
detailed characterization of genotype-phenotype correlations. 
 
